This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges... Nov 21
A study of measles-mumps-rubella titers and SARS-CoV-2 infection severity was published in mBio, the open-access journal of the American Society ... Nov 21
RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease ... Nov 21
AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
The company believes that OTL-200 offers tremendous potential to transform the lives of many young patients with MLD... Nov 21
VFMCRP and Fresenius Kabi will deliver a treatment that will enable patients to remain on RAASi therapy by managing their chronic hyperkalemia... Nov 21
-Advertisements-